المؤلفون: Pires da Silva, I., Zakria, D., Ahmed, T., Trojanello, C., Dimitriou, F., Allayous, C., Gerard, C., Zimmer, L., Lo, S., Michielin, O., Lebbe, C., Mangana, J., Ascierto, P.A., Johnson, D.B., Carlino, M., Menzies, A., Long, G.

المصدر: Journal for immunotherapy of cancer, vol. 10, no. 7, pp. e004610

مصطلحات موضوعية: Brain Neoplasms/drug therapy, Female, Humans, Ipilimumab/therapeutic use, Melanoma/drug therapy, Melanoma/genetics, Melanoma/pathology, Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors, Mutation, Neoplasms, Second Primary/drug therapy, Protein Kinase Inhibitors/adverse effects, Protein Kinase Inhibitors/therapeutic use, Proto-Oncogene Proteins B-raf/antagonists & inhibitors, Proto-Oncogene Proteins B-raf/genetics, Skin Neoplasms/drug therapy, Skin Neoplasms/genetics, Skin Neoplasms/pathology, immunotherapy, melanoma

وصف الملف: application/pdf

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35798536; info:eu-repo/semantics/altIdentifier/eissn/2051-1426; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_D204CE09BBCB7; https://serval.unil.ch/notice/serval:BIB_D204CE09BBCBTest; urn:issn:2051-1426; https://serval.unil.ch/resource/serval:BIB_D204CE09BBCB.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_D204CE09BBCB7Test

الإتاحة: https://doi.org/10.1136/jitc-2022-004610Test
https://serval.unil.ch/notice/serval:BIB_D204CE09BBCBTest
https://serval.unil.ch/resource/serval:BIB_D204CE09BBCB.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_D204CE09BBCB7Test

المؤلفون: Bhave, P., Ahmed, T., Lo, S.N., Shoushtari, A., Zaremba, A., Versluis, J.M., Mangana, J., Weichenthal, M., Si, L., Lesimple, T., Robert, C., Trojanello, C., Wicky, A., Heywood, R., Tran, L., Batty, K., Dimitriou, F., Stansfeld, A., Allayous, C., Schwarze, J.K., Mooradian, M.J., Klein, O., Mehmi, I., Roberts-Thomson, R., Maurichi, A., Yeoh, H.L., Khattak, A., Zimmer, L., Blank, C.U., Ramelyte, E., Kähler, K.C., Roy, S., Ascierto, P.A., Michielin, O., Lorigan, P.C., Johnson, D.B., Plummer, R., Lebbe, C., Neyns, B., Sullivan, R., Hamid, O., Santinami, M., McArthur, G.A., Haydon, A.M., Long, G.V., Menzies, A.M., Carlino, M.S.

المصدر: Journal for immunotherapy of cancer, vol. 10, no. 7, pp. e004668

مصطلحات موضوعية: Humans, Ipilimumab/pharmacology, Ipilimumab/therapeutic use, Melanoma/drug therapy, Prospective Studies, Retrospective Studies, Skin Neoplasms, CTLA-4 Antigen, Immunotherapy, Melanoma, Programmed Cell Death 1 Receptor

وصف الملف: application/pdf

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35793872; info:eu-repo/semantics/altIdentifier/eissn/2051-1426; https://serval.unil.ch/notice/serval:BIB_B4F52EB38286Test; urn:issn:2051-1426; https://serval.unil.ch/resource/serval:BIB_B4F52EB38286.P001/REF.pdfTest

الإتاحة: https://doi.org/10.1136/jitc-2022-004668Test
https://serval.unil.ch/notice/serval:BIB_B4F52EB38286Test
https://serval.unil.ch/resource/serval:BIB_B4F52EB38286.P001/REF.pdfTest